AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32271970 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID
Number of subjects: 0
Study 32271970 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg subcutaneous injection every 2 weeks (only in OPAL Broaden)
Number of subjects: 0
Study 32271970 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32356365 — intervention group
Group type: EXPERIMENTAL
Intervention: Super high-flux hemodialysis (SHF-HD)
Number of subjects: 15
Study 32356365 — intervention group
Group type: COMPARATOR
Intervention: High-volume postdilution online hemodiafiltration (ol-HDF)
Number of subjects: 15
Study 34600314 — intervention group
Group type: EXPERIMENTAL
Intervention: Original RICWS design
Number of subjects: 120
Study 34600314 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative RICWS Designs (except for Alternative RICWS Design 1)
Number of subjects: 120
Study 34600314 — intervention group
Group type: COMPARATOR
Intervention: Control intersections
Number of subjects: 120
Study 34261874 — intervention group
Group type: EXPERIMENTAL
Intervention: HeartMate Percutaneous Heart Pump (PHP)
Number of subjects: 75
Study 35274691 — intervention group
Group type: EXPERIMENTAL
Intervention: Anifrolumab (300 mg every 4 weeks for 48 weeks)
Number of subjects: 726
Study 35274691 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 726
Study 33230938 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex functional training intervention initiated by physiotherapist and performed by nurses/nurse assistants (NAs) as part of daily routine
Number of subjects: 0
Study 33230938 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 32764887 — intervention group
Group type: EXPERIMENTAL
Intervention: BD-TAP block with 3 mg/kg of ropivacaine diluted to 60 mL
Number of subjects: 50
Study 32764887 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (Control)
Number of subjects: 50
Study 33397654 — intervention group
Group type: EXPERIMENTAL
Intervention: Macular Buckling (MB)
Number of subjects: 53
Study 33397654 — intervention group
Group type: COMPARATOR
Intervention: Pars Plana Vitrectomy (PPV)
Number of subjects: 53
Study 32415468 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib (single-dose administration)
Number of subjects: 26
Study 32415468 — intervention group
Group type: COMPARATOR
Intervention: CYP2B6 516GT carriers
Number of subjects: 26
Study 32415468 — intervention group
Group type: COMPARATOR
Intervention: CYP3A4 (*22/*22, *1/*20 and *1/*22 variants)
Number of subjects: 26
Study 34568362 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine (0.1 mg/kg bolus after anesthesia induction, 0.1 mg/kg/h during operation, 0.015 mg/kg/h in PCIA after surgery)
Number of subjects: 0
Study 34568362 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine
Number of subjects: 0
Study 34568362 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Control Group)
Number of subjects: 0
Study 33380574 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal epidural injections with 1% lidocaine hydrochloride mixed with triamcinolone
Number of subjects: 47
Study 33380574 — intervention group
Group type: COMPARATOR
Intervention: No injections (Control Group)
Number of subjects: 47
Study 34428536 — intervention group
Group type: EXPERIMENTAL
Intervention: urodynamics ultrasound (uUS)
Number of subjects: 10
Study 34428536 — intervention group
Group type: COMPARATOR
Intervention: traditional ultrasound (tUS)
Number of subjects: 10
Study 33473211 — intervention group
Group type: COMPARATOR
Intervention: Recruiters contacting individuals from immigrant and minority ethnic groups
Number of subjects: 0
Study 33473211 — intervention group
Group type: COMPARATOR
Intervention: Women in male-dominated professions
Number of subjects: 0
Study 33473211 — intervention group
Group type: COMPARATOR
Intervention: Men in female-dominated professions
Number of subjects: 0
Study 33473211 — intervention group
Group type: COMPARATOR
Intervention: Evaluation time by recruiters
Number of subjects: 0
Study 32231364 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Adapt Therapy (IAT)
Number of subjects: 331
Study 36183751 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfermented dietary β-fructan fibers
Number of subjects: 0
Study 36183751 — intervention group
Group type: COMPARATOR
Intervention: Fermentation of β-fructans by human gut whole microbiota cultures
Number of subjects: 0
Study 34675369 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased maternal BMI in mid‐gestation
Number of subjects: 57
Study 34675369 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater maternal BMI
Number of subjects: 57
Study 34675369 — intervention group
Group type: EXPERIMENTAL
Intervention: Excessive GWG
Number of subjects: 57
Study 34675369 — intervention group
Group type: COMPARATOR
Intervention: Normal-weight mothers with adequate and excessive GWG
Number of subjects: 57
Study 32385063 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole milk recommendation
Number of subjects: 534
Study 32385063 — intervention group
Group type: COMPARATOR
Intervention: Reduced (1%) fat milk recommendation
Number of subjects: 534
Study 33932990 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 infusion (Group G)
Number of subjects: 41
Study 33932990 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 + Theophylline infusion (Group GT)
Number of subjects: 41
Study 33932990 — intervention group
Group type: COMPARATOR
Intervention: Theophylline infusion (Group T)
Number of subjects: 41
Study 32730173 — intervention group
Group type: EXPERIMENTAL
Intervention: Low PEEP (1 cmH2O)
Number of subjects: 19
Study 32730173 — intervention group
Group type: EXPERIMENTAL
Intervention: High PEEP (9 cmH2O)
Number of subjects: 19
Study 32730173 — intervention group
Group type: EXPERIMENTAL
Intervention: Low PEEP MV + surgical laparotomy (LAP)
Number of subjects: 19
Study 32730173 — intervention group
Group type: EXPERIMENTAL
Intervention: High PEEP MV + pneumothorax (PTX)
Number of subjects: 19
Study 35546454 — intervention group
Group type: EXPERIMENTAL
Intervention: APR-RARP
Number of subjects: 80
Study 35546454 — intervention group
Group type: COMPARATOR
Intervention: RS-RARP
Number of subjects: 80
Study 33222710 — intervention group
Group type: EXPERIMENTAL
Intervention: Ready-to-use therapeutic food (RUTF) sourced from Compact India
Number of subjects: 906
Study 33222710 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally prepared RUTF
Number of subjects: 906
Study 33222710 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented home-prepared foods
Number of subjects: 906
Study 33222710 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment phase without hospitalisation
Number of subjects: 906
Study 33222710 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment phase without fever
Number of subjects: 906
Study 33222710 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment phase with ≤ 2 episodes of diarrhoea
Number of subjects: 906
Study 33222710 — intervention group
Group type: EXPERIMENTAL
Intervention: Availability of community-based peer support to mothers for feeding
Number of subjects: 906
Study 33222710 — intervention group
Group type: EXPERIMENTAL
Intervention: Better weight-for-height Z-score (WHZ) at enrolment
Number of subjects: 906
Study 32488885 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone 20 mg
Number of subjects: 0
Study 32488885 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone 60 mg
Number of subjects: 0
Study 32488885 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone 140 mg
Number of subjects: 0
Study 32488885 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg
Number of subjects: 0
Study 32488885 — intervention group
Group type: COMPARATOR
Intervention: Trazodone-matched placebo
Number of subjects: 0
Study 35763660 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-FNA (Echotip 22Gauge FNA needle)
Number of subjects: 100
Study 35763660 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-FNB (22Gauge acquire FNB needle)
Number of subjects: 100
Study 35763660 — intervention group
Group type: COMPARATOR
Intervention: EUS-FNA
Number of subjects: 100
Study 35763660 — intervention group
Group type: COMPARATOR
Intervention: EUS-FNB
Number of subjects: 100
Study 32757075 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% CHX + 1.5% H2O2 mouthrinse
Number of subjects: 60
Study 32757075 — intervention group
Group type: COMPARATOR
Intervention: 0.12% CHX
Number of subjects: 60
Study 35623631 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer‐facilitated trauma‐specific intervention (Exploring Trauma: A 6‐Session Brief Intervention for Men)
Number of subjects: 221
Study 35623631 — intervention group
Group type: COMPARATOR
Intervention: Waitlisted control group
Number of subjects: 221
Study 34444703 — intervention group
Group type: EXPERIMENTAL
Intervention: β-alanine (20 g per day for 7 days)
Number of subjects: 12
Study 34444703 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 32418818 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 2178
Study 35764009 — intervention group
Group type: EXPERIMENTAL
Intervention: SFA
Number of subjects: 8
Study 35764009 — intervention group
Group type: EXPERIMENTAL
Intervention: FO
Number of subjects: 8
Study 35764009 — intervention group
Group type: COMPARATOR
Intervention: Con
Number of subjects: 8
Study 34172032 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality distraction (watching a cartoon video using virtual reality goggles)
Number of subjects: 50
Study 34172032 — intervention group
Group type: COMPARATOR
Intervention: Control group (watching a cartoon video on a screen)
Number of subjects: 50
Study 34172032 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (regardless of distraction technique)
Number of subjects: 50
Study 33355605 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistently short or consistently long femur lengths (FL)
Number of subjects: 498
Study 33355605 — intervention group
Group type: EXPERIMENTAL
Intervention: Faster growth trajectories of head circumference (HC), femur length (FL), or estimated fetal weight (EFW)
Number of subjects: 498
Study 36323344 — intervention group
Group type: EXPERIMENTAL
Intervention: Greenlight intervention
Number of subjects: 900
Study 36323344 — intervention group
Group type: EXPERIMENTAL
Intervention: Greenlight Plus intervention
Number of subjects: 900
Study 32516282 — intervention group
Group type: EXPERIMENTAL
Intervention: Baloxavir
Number of subjects: 173
Study 32516282 — intervention group
Group type: COMPARATOR
Intervention: Oseltamivir
Number of subjects: 173
Study 35103836 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg of ibuprofen, administered intravenously twice daily.
Number of subjects: 109
Study 35103836 — intervention group
Group type: COMPARATOR
Intervention: 75 mg diclofenac plus 30 mg orphenadrine, administered intravenously twice daily.
Number of subjects: 109
Study 35716692 — intervention group
Group type: EXPERIMENTAL
Intervention: eptinezumab 100 mg
Number of subjects: 891
Study 35716692 — intervention group
Group type: EXPERIMENTAL
Intervention: eptinezumab 300 mg
Number of subjects: 891
Study 35716692 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 891
Study 32545689 — intervention group
Group type: EXPERIMENTAL
Intervention: CpG‐A (100 g/kg)
Number of subjects: 42
Study 32545689 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 32545689 — intervention group
Group type: EXPERIMENTAL
Intervention: CpG‐A and Placebo
Number of subjects: 42
Study 35546299 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) with 915 nm diode laser (1.5 W, duty cycle of 60%, energy density of 72 J/cm2)
Number of subjects: 32
Study 35546299 — intervention group
Group type: COMPARATOR
Intervention: Sham laser (no irradiation)
Number of subjects: 32
Study 33084019 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health educational and behavioral intervention program (two 1-hour sessions)
Number of subjects: 66
Study 33084019 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 66
Study 34088322 — intervention group
Group type: EXPERIMENTAL
Intervention: L-tyrosine-adsorbed allergen extracts
Number of subjects: 0
Study 34088322 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 0
Study 32297283 — intervention group
Group type: EXPERIMENTAL
Intervention: OPTIMA-PA questionnaire
Number of subjects: 154
Study 32297283 — intervention group
Group type: COMPARATOR
Intervention: Standard group (usual clinical practice)
Number of subjects: 154
Study 32297283 — intervention group
Group type: EXPERIMENTAL
Intervention: GP patient-centredness
Number of subjects: 154
Study 32140973 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-week exercise intervention
Number of subjects: 240
Study 32996802 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 101
Study 32996802 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 101
Study 35696128 — intervention group
Group type: EXPERIMENTAL
Intervention: Red blood cell transfusions from female donors
Number of subjects: 368778
Study 35696128 — intervention group
Group type: EXPERIMENTAL
Intervention: Red blood cell transfusions from parous female donors
Number of subjects: 368778
Study 35696128 — intervention group
Group type: COMPARATOR
Intervention: Red blood cell transfusions from male donors
Number of subjects: 368778
Study 34319221 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning models using metadata and text features for suicidality detection.
Number of subjects: 20000
Study 34319221 — intervention group
Group type: EXPERIMENTAL
Intervention: Metadata features including posting type (reply vs. original), time of day, and day of the week.
Number of subjects: 20000
Study 32718986 — intervention group
Group type: EXPERIMENTAL
Intervention: adagloxad simolenin (AS/OBI-821) with adjuvant OBI-821
Number of subjects: 349
Study 32718986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 349
Study 32718986 — intervention group
Group type: EXPERIMENTAL
Intervention: adagloxad simolenin (AS/OBI-821) with anti-Globo H IgG titer ≥1:160
Number of subjects: 349
Study 32718986 — intervention group
Group type: EXPERIMENTAL
Intervention: adagloxad simolenin (AS/OBI-821) with anti-Globo H IgG titer <1:160
Number of subjects: 349
Study 32718986 — intervention group
Group type: EXPERIMENTAL
Intervention: AS/OBI-821
Number of subjects: 349
Study 36109599 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric exercise training (IET)
Number of subjects: 24
Study 34604396 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal massage with extra-virgin olive oil for five consecutive days (15 minutes each day)
Number of subjects: 54
Study 34604396 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal massage with water for five consecutive days (15 minutes each day)
Number of subjects: 54
Study 34604396 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention)
Number of subjects: 54
Study 36274285 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior tibial nerve stimulation (PTNS)
Number of subjects: 40
Study 36274285 — intervention group
Group type: COMPARATOR
Intervention: Control group (pelvic floor muscle training)
Number of subjects: 40
Study 35316372 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week supervised concurrent chair-based exercise program (stretching, strength, balance exercises, aerobic dance; 5 days/week, 30-40 min/day, 2 workouts/day lasted 15-20 min)
Number of subjects: 50
Study 35316372 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 50
Study 32280208 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal medicines (CHMs)
Number of subjects: 3360
Study 32280208 — intervention group
Group type: COMPARATOR
Intervention: Non-CHMs users
Number of subjects: 3360
Study 35770308 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional Er: YAG 2940 nm laser
Number of subjects: 20
Study 35770308 — intervention group
Group type: COMPARATOR
Intervention: Q‐Switched Nd: YAG 1064 nm laser
Number of subjects: 20
Study 35770308 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient satisfaction levels after treatment in Area A (Fractional Er: YAG)
Number of subjects: 20
Study 32632986 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg
Number of subjects: 17
Study 32632986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 32623977 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure-lowering therapy (target systolic BP, 110-139 mm Hg)
Number of subjects: 1000
Study 32623977 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure-lowering therapy (target systolic BP, 140-179 mm Hg)
Number of subjects: 1000
Study 32623977 — intervention group
Group type: COMPARATOR
Intervention: Comparison of intensive vs standard BP-lowering therapy
Number of subjects: 1000
Study 33791377 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) therapy at the surgical site
Number of subjects: 12
Study 33791377 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PRP therapy)
Number of subjects: 12
Study 32663149 — intervention group
Group type: EXPERIMENTAL
Intervention: Response rates among older men (aged 65-70)
Number of subjects: 6756
Study 32663149 — intervention group
Group type: EXPERIMENTAL
Intervention: Response rates in rural areas
Number of subjects: 6756
Study 32663149 — intervention group
Group type: EXPERIMENTAL
Intervention: Response rates in areas with higher tax base
Number of subjects: 6756
Study 35576245 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided bone regeneration (GBR) with xenograft (DBBM, Bio‐Oss®) and absorbable membrane (Bio‐Gide®)
Number of subjects: 67
Study 35576245 — intervention group
Group type: COMPARATOR
Intervention: Cystectomy without any filling material (Control group)
Number of subjects: 67
Study 34549922 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetric EvoCeram Bulk Fill with a 4-mm layer thickness
Number of subjects: 94
Study 34549922 — intervention group
Group type: EXPERIMENTAL
Intervention: SDR in combination with Tetric EvoCeram Bulk Fill with a 2-mm layer thickness
Number of subjects: 94
Study 34549922 — intervention group
Group type: COMPARATOR
Intervention: Tetric EvoCeram with a 2-mm layer thickness
Number of subjects: 94
Study 36521773 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture intervention combined with pharmacologic treatment
Number of subjects: 0
Study 36521773 — intervention group
Group type: COMPARATOR
Intervention: Pharmacologic treatment only (Control)
Number of subjects: 0
Study 32168288 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity (HF) simulation-based learning on themes A, B, and C
Number of subjects: 166
Study 32168288 — intervention group
Group type: COMPARATOR
Intervention: Standard education on themes D, E, and F
Number of subjects: 166
Study 32168288 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity (HF) simulation-based learning
Number of subjects: 166
Study 32168288 — intervention group
Group type: COMPARATOR
Intervention: Standard education
Number of subjects: 166
Study 35044992 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental intervention (pushing a medicine ball attached to the ceiling using their unaffected upper extremity)
Number of subjects: 6
Study 35044992 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (self‐guided general mobility exercise program)
Number of subjects: 6
Study 35044992 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental intervention
Number of subjects: 6
Study 35010951 — intervention group
Group type: EXPERIMENTAL
Intervention: High Stress (HS) group
Number of subjects: 61
Study 35010951 — intervention group
Group type: COMPARATOR
Intervention: Very High Stress (VHS) group
Number of subjects: 61
Study 35167700 — intervention group
Group type: EXPERIMENTAL
Intervention: mild Procedure + Conventional Medical Management (CMM)
Number of subjects: 138
Study 35167700 — intervention group
Group type: COMPARATOR
Intervention: Conventional Medical Management (CMM) alone
Number of subjects: 138
Study 35167700 — intervention group
Group type: EXPERIMENTAL
Intervention: mild Procedure + CMM
Number of subjects: 138
Study 35167700 — intervention group
Group type: COMPARATOR
Intervention: CMM alone
Number of subjects: 138
Study 32706181 — intervention group
Group type: EXPERIMENTAL
Intervention: Finnish RCT
Number of subjects: 403
Study 32706181 — intervention group
Group type: COMPARATOR
Intervention: Singaporean SCORM Matched 9-year-olds
Number of subjects: 403
Study 32706181 — intervention group
Group type: EXPERIMENTAL
Intervention: Finnish RCT 11-year-olds
Number of subjects: 403
Study 32706181 — intervention group
Group type: COMPARATOR
Intervention: Singaporean SCORM Matched 11-year-olds
Number of subjects: 403
Study 32706181 — intervention group
Group type: EXPERIMENTAL
Intervention: SCORM 7-year-olds
Number of subjects: 403
Study 32706181 — intervention group
Group type: COMPARATOR
Intervention: Singaporean SCORM Matched
Number of subjects: 403
Study 32482112 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate (70 mg/week, n=22)
Number of subjects: 60
Study 32482112 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human parathyroid hormone (20 μg/day, n=35)
Number of subjects: 60
Study 35719024 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Focused Therapy (FFT-CHR)
Number of subjects: 129
Study 35719024 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Care (EC)
Number of subjects: 129
Study 33648576 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended cognitive behaviour therapy (PowerMe intervention) targeting fatigue, tailored to individual treatment plans, duration of 33 weeks with a baseline period of 5 to 9 weeks before intervention.
Number of subjects: 10
Study 32700409 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacy care (n = 110)
Number of subjects: 237
Study 32700409 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n = 127)
Number of subjects: 237
Study 33035763 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly oral health intervention by dental hygienists for 8 months
Number of subjects: 55
Study 33035763 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 55
Study 32565477 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) teaching for SSI prevention measures
Number of subjects: 3
Study 32565477 — intervention group
Group type: COMPARATOR
Intervention: Conventional education programme
Number of subjects: 3
Study 35073805 — intervention group
Group type: EXPERIMENTAL
Intervention: Specificity prompts
Number of subjects: 228